How This Biotech Stock Gave Us a Triple-Digit Gain

We Gained 148% on MRNA in 3 Days. Here's How

If you keep up with the stock market like WealthPress Senior Strategist Roger Scott does — even while he's vacationing at Lake Winnipesaukee in New Hampshire — then you've probably heard Thursday evening's news by now…

Moderna's being added to the S&P 500!

As savvy traders and investors would expect, the stock jumped — big time! Moderna was trading at $277.84 per share when he alerted his First Strike Portfolio members to sell their Sept. 17 $250 strike calls...

And they locked in a nice 148.4% gain in just three days!

Here's How They Did It

Jeff Z

Jeff Zananiri spent over two decades on Wall Street learning how the best made consistent money in the market.

The Everyday Trader's Holy Grail

What if traders could place a simple trade at 3:59 p.m. every day…

Walk away…

And come back the next morning to cash out with overnight wins like 126% on Facebook.

Thanks to this repeating Wall Street pattern, traders can get in front of double-digit explosions.

Try It out Here

These Are the 3 Hottest Breakout Stocks Worth Watching

July 18, 2021

When WealthPress Senior Strategist Roger Scott began to film today's video, the Nasdaq was hovering near its record high.

Continue Reading

The Stock Market Is Selling Off. Here's How You Should Play It

July 19, 2021

Bad news, guys... It looks like the next stock market sell-off is in July.

Continue Reading

Disclaimer:
The material in this document is for informational purposes based on our proprietary research. It is not an offering, specific recommendation, or a solicitation of an offer to buy or sell any securities mentioned or discussed herein.

Any performance results discussed herein represent past performance, are not a guarantee of future performance, and are not indicative of any specific investment.

Due to the timing of information presented, any investment performance reflected within this document may be adjusted after the publication and distribution of this material. There can be no assurance that the future performance of any specific investment, investment strategy, or product made reference to directly or indirectly in this communication will be profitable, be equal to any corresponding indicated historical performance levels or be suitable for your portfolio. Any investment results set forth in this document are not net of expenses and execution costs, nor do they account for other relevant trading or investment fees. Please visit wealthpress.com/terms for our full Terms and Conditions.